← All peptides
Hormones & TRT
Clinical

Clomiphene

Also known as: Clomid, Clomiphene citrate

A selective estrogen receptor modulator (SERM) used off-label to raise endogenous testosterone and to restart natural production in post-cycle therapy. Prescription medication (approved for female fertility).

Last updated

Mechanism of Action

Clomiphene blocks estrogen receptors at the hypothalamus and pituitary, removing negative feedback so the body secretes more GnRH, LH, and FSH — which raises endogenous testosterone and supports spermatogenesis. It is a mixture of two isomers: enclomiphene (trans, the anti-estrogenic driver) and zuclomiphene (cis, longer-acting and more estrogenic), which is why side-effect profiles differ from pure enclomiphene.

Half-life
Mixed — days for enclomiphene, weeks for the zuclomiphene isomer
Administration Routes
Oral
Research Status
Clinical

Reported Benefits

  • Raises endogenous testosterone without exogenous hormone
  • Preserves fertility and testicular function
  • Used in post-cycle protocols to restart natural production

Potential Side Effects

  • Mood changes, irritability (partly the zuclomiphene isomer)
  • Visual disturbances (rare, SERM class effect)
  • Elevated estradiol in some users

Common Dosing

Reported off-label protocols use a low oral daily or every-other-day dose, or a tapering course in PCT, titrated to labs and symptoms. Investigational for men; use only under medical supervision.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Pre-existing visual disorders
  • Hormone-sensitive conditions
  • Liver disease
  • Use only under medical supervision
  • Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism

    2019

    View
  • Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study

    2018

    View
  • A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men

    2015

    View
  • Clomiphene citrate versus testosterone replacement therapy in male hypogonadism: a systematic review of literature and meta-analysis

    2026

    View
  • Clomiphene Citrate in off-Label Post-Cycle Therapy: Mechanisms, Efficacy and Diagnostic Challenges in Endocrine Recovery Following Anabolic Steroid Use

    2026

    View

Enclomiphene is the isolated trans-isomer of clomiphene. Clomiphene also contains zuclomiphene, which is more estrogenic and longer-lasting, so enclomiphene tends to have a cleaner side-effect profile. Both are prescription/investigational and physician-guided.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.